Upgrade to SI Premium - Free Trial

Edgewise Therapeutics Inc. (EWTX)

33.30 -1.91 (5.42%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Biotech Bulls Stampede as Clinical Wins and Milestones Fuel Momentum June 16, 2026 10:19 AM - StreetInsider Truist Securities Reiterates Buy Rating on Edgewise Therapeutics (EWTX) June 16, 2026 9:00 AM - StreetInsider Leerink: 'CIRRUS Part D data continue to look supportive of EDG-7500’s potential' June 16, 2026 8:55 AM - StreetInsider SpaceX, Rackspace surge premarket; Edgewise Therapeutics, Huntsman fall June 16, 2026 8:18 AM - StreetInsider EDGEWISE reports Phase 2 HCM trial results for EDG-7500 June 16, 2026 7:00 AM - StreetInsider Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM) June 16, 2026 7:00 AM - PR NewsWire Form 8-K Edgewise Therapeutics, For: Jun 04 June 5, 2026 4:33 PM - SEC Filing Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules June 3, 2026 4:01 PM - PR NewsWire Edgewise Therapeutics (EWTX) PT Lowered to $48 at RBC Capital June 2, 2026 7:16 AM - StreetInsider Edgewise Therapeutics (EWTX) PT Raised to $66 at Raymond James June 1, 2026 2:16 PM - StreetInsider Edgewise Therapeutics (EWTX) PT Raised to $52 at Wedbush June 1, 2026 2:09 PM - StreetInsider Form 8-K Edgewise Therapeutics, For: May 31 June 1, 2026 8:51 AM - SEC Filing Edgewise Therapeutics sells sevasemten to Servier for up to $2.65 billion June 1, 2026 8:31 AM - StreetInsider Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline June 1, 2026 8:30 AM - PR NewsWire Servier to acquire Edgewise muscular dystrophy business for $2.65 billion June 1, 2026 8:30 AM - StreetInsider Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business June 1, 2026 8:30 AM - PR NewsWire Form SCHEDULE 13G Edgewise Therapeutics, Filed by: JANUS HENDERSON GROUP PLC May 15, 2026 11:43 AM - SEC Filing Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 20, 2026 May 12, 2026 8:00 AM - PR NewsWire Form S-8 Edgewise Therapeutics, May 7, 2026 5:18 PM - SEC Filing Form 8-K Edgewise Therapeutics, For: May 07 May 7, 2026 9:21 AM - SEC Filing Form 10-Q Edgewise Therapeutics, For: Mar 31 May 7, 2026 8:10 AM - SEC Filing Edgewise Therapeutics, Inc. (EWTX) Tops Q1 EPS by 3c May 7, 2026 8:04 AM - StreetInsider Edgewise Therapeutics Reports First Quarter 2026 Financial Results and Advances Clinical Programs in Muscular Dystrophy and Cardiovascular Indications May 7, 2026 8:00 AM - PR NewsWire Edgewise Therapeutics (EWTX) PT Raised to $52 at Truist Securities May 6, 2026 7:11 AM - StreetInsider Form 144 Edgewise Therapeutics, Filed by: Donovan Joanne M. May 5, 2026 4:30 PM - SEC Filing Form 4 Edgewise Therapeutics, For: May 04 Filed by: Donovan Joanne M. May 5, 2026 1:15 PM - SEC Filing Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules May 4, 2026 8:00 AM - PR NewsWire Form SCHEDULE 13D/A Edgewise Therapeutics, Filed by: Novo Holdings A/S April 27, 2026 4:49 PM - SEC Filing Form ARS Edgewise Therapeutics, For: Dec 31 April 23, 2026 7:01 PM - SEC Filing Form DEFA14A Edgewise Therapeutics, April 23, 2026 7:00 PM - SEC Filing Form DEF 14A Edgewise Therapeutics, For: Jun 04 April 23, 2026 7:00 PM - SEC Filing Form 4 Edgewise Therapeutics, For: Apr 01 Filed by: Fox Jonathan C April 3, 2026 2:12 PM - SEC Filing Form 4 Edgewise Therapeutics, For: Apr 01 Filed by: Donovan Joanne M. April 2, 2026 1:01 PM - SEC Filing Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules April 1, 2026 8:01 AM - PR NewsWire Form 4 Edgewise Therapeutics, For: Mar 31 Filed by: Donovan Joanne M. March 31, 2026 7:34 PM - SEC Filing Form 4 Edgewise Therapeutics, For: Mar 27 Filed by: Donovan Joanne M. March 30, 2026 5:37 PM - SEC Filing Form 144 Edgewise Therapeutics, Filed by: Donovan Joanne M. March 27, 2026 4:41 PM - SEC Filing Full Article List